Merck to buy Prometheus Biosciences for $10.8 billion
Drug maker Merck & Co. Inc. announced Sunday a deal to acquire Prometheus Biosciences Inc. for $200 a share, or ...
Read moreDrug maker Merck & Co. Inc. announced Sunday a deal to acquire Prometheus Biosciences Inc. for $200 a share, or ...
Read moreModerna Inc. said Tuesday it’s working to develop its first bacterial vaccine to protect against Lyme disease, the tick-borne illness ...
Read moreCanadian pot producer Tilray Brands Inc. on Monday said it agreed to buy peer Hexo Corp. for $56 million in ...
Read moreJohnson & Johnson stock rose more than 3% in the extended session Tuesday after the company said it has proposed ...
Read moreBill Hearn’s medication to treat his mild chronic obstructive pulmonary disease, or COPD, would cost him $275 per month from ...
Read moreChina is reporting mixed economic news following last week’s political gathering that saw President Xi Jinping strengthen his grip on ...
Read moreAmgen Inc. on Thursday said it would lay off about 450 employees, or less than 2% of its workforce, as ...
Read moreEli Lilly’s announcement that it will cut the price of insulin for people with commercial health insurance — capping out-of-pocket ...
Read morePfizer Inc. PFE, -1.30% is in talks to acquire biotech Seagen Inc. SGEN, -0.51%, according to people familiar with the matter, the latest ...
Read moreMany of the people in the U.S. who pay hundreds of dollars every few months to get Botox plan to ...
Read moreTodayheadline the independent news and topics discovery
A home-grown and independent news and topic aggregation . displays breaking news linking to news websites all around the world.
© 2024 All rights are reserved Today Headline